Secure Asset Management’s Gilead Sciences GILD Stock Holding History

Secure Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,554	Closed	-$258K	–	215
2021 Q4	$258K	Buy	3,554 +240	+7%	+$16.5K	0.1%	166
2021 Q3	$231K	Sell	3,314 -2,642	-44%	-$186K	0.11%	156
2021 Q2	$410K	Buy	5,956 +2,661	+81%	+$178K	0.21%	99
2021 Q1	$213K	Buy	+3,295	New	+$212K	0.12%	166

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Secure Asset Management's GILD Position: Q1 2022 in Review

Secure Asset Management sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 3,554 shares — an estimated $258K sold.

Secure Asset Management first reported a position in GILD in Q1 2021 and held it in 4 quarters. The position peaked at $410K in Q2 2021. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

Secure Asset Management reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
Secure Asset Management sold 3,554 Gilead Sciences shares in Q1 2022, an estimated $258K.
Secure Asset Management first reported a position in Gilead Sciences in Q1 2021 and held it in 4 quarters.
Secure Asset Management's Gilead Sciences position peaked at $410K in Q2 2021.
1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Secure Asset Management's 13F filing for Q1 2022, filed 19 Apr 2022.